Search the Site


test tubes

Shares of $MNKD continue to drop after CRL

publication date: Jan 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Last week MNKD recieved a CRL causing shares to drop about 25%.  This drop was not nearly as severe as I had expected, especially considering the long path ahead for MNKD.  Multiple clinical trials as well as possible dilution.  I was expecteing to see MNKD immediately trading in the $4 range, possibly as low as the mid $3's.  When shares only dipped into the $5's and bounced to the $6's I re-read the press releases and looked for a possible reason why share price was holding up so well- in fact they were stayin in the bottom range of the run-up.

Sorry this page is available to subscribers only. 

You can also sign up for our 100% FREE Newsletter  to stay current on public webinars, special offers, and news alerts:


If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.